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Due to its limited genomic capacity, HIV-1 must interact
with several cellular partners to replicate. Integration of a
cDNA copy of its RNA genome into a chromosome of the
host cell is a key step of retroviral replication that is under
the control of Integrase. Although, the recombinant inte-
grase is necessary and sufficient to catalyze the integration
reaction in vitro, numerous studies have showed that cel-
lular cofactors of integrase are involved in viral replica-
tion. Large-scale yeast two-hybrid screening (y2HS) has
been proven to be a powerful approach to identify new
protein-protein interactions. Using this method, we were
able to isolate several new host cofactors interacting with
integrase.
Together, our studies have identified the human lens epi-
thelium-derived growth factor (LEDGF/p75), Transpor-
tin-SR2 (TNPO3), and von Hippel-Lindau binding
protein 1 (VBP1) as cellular binding partners of HIV-1
integrase. For these cell factors, we have generated and
characterized loss of affinity mutants of integrase, which,
when combined with viral functional assays, validated
their involvement in early step of the HIV-1 replication
cycle. Using a biochemical approach to follow PIC com-
ponents in different cellular compartments, the dynamic
interaction between integrase and cellular cofactors was
further explored within infected cells. Cellular cofactors
are required for the completion of the HIV replication
cycle and it is critical to elucidate on their mechanism of
action. Novel therapeutic strategies aim to develop antivi-
ral compounds targeting interactions between integrase
and host-cell partners. Such novel targets are continuously
needed to overcome the problem linked to the somewhat
frequent occurrence of multi-drug-resistance, that in turn
leads to complete therapeutic failure for patients infected
with drug resistant viral strains.
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